Fundz

Factor Bioscience Adds Kyle Garland, Ph.D. as Director of Translational Science

RECENTLY ACQUIREDApr 09, 2024

Position

Vice President of Research and Development

Company

Factor Bioscience

Kyle Garland
kyle.garland@factorbio.com
CambridgeBiotechnologyHealth Care

Description

Factor Bioscience Inc. announced the addition of three members to its translational science team, led by Kyle Garland, Ph.D., who joins as Director of Translational Science.

Who to call at Factor Bioscience, and when

A new leader at Factor Bioscience brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Factor Bioscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Factor Bioscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Factor Bioscience. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Factor Bioscience

Location

Cambridge, Massachusetts, United States

About

Factor Bioscience was founded to pioneer new methods for controlling gene expression and cell fate. The company innovates across mRNA, gene editing, cell reprogramming, and nucleic acid delivery. With more than 150 granted patents, Factor Bioscience has helped unlock the potential of mRNA to treat disease and improve lives. Factor supports a model of unlimited discovery, believing that breakthroughs happen when scientists are given the freedom and resources to pursue bold ideas. At Factor Bioscience, science is the business. Partner with Factor Bioscience to build the next generation of cell therapies, gene therapies, and RNA therapeutics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Factor Bioscience changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Kyle
Likely contact at this company
••••••••@••••••••

See Kyle's verified email →

Matt
Likely contact at this company
••••••••@••••••••

See Matt's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Factor Bioscience's next move

Learn about Strategic plan

Factor Bioscience changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.